Latest filings (excl ownership)
10-K
2023 FY
Annual report
21 Mar 24
8-K
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
21 Mar 24
8-K
Other Events
21 Feb 24
8-K
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication
22 Jan 24
8-K
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
8 Jan 24
8-K
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
28 Nov 23
S-8
Registration of securities for employees
16 Nov 23
8-K
Departure of Directors or Certain Officers
16 Nov 23
S-8
Registration of securities for employees
16 Nov 23
8-K
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
9 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
9 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
16 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook
10 Aug 23
DEF 14A
Definitive proxy
23 Jun 23
SD
Conflict minerals disclosure
31 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
11 May 23
8-K
Entry into a Material Definitive Agreement
18 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
8-K
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook
16 Mar 23
8-K
Entry into a Material Definitive Agreement
15 Mar 23
8-K
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial
24 Feb 23
8-K
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
10 Jan 23
EFFECT
Notice of effectiveness
5 Dec 22
S-3/A
Shelf registration (amended)
2 Dec 22
CORRESP
Correspondence with SEC
30 Nov 22
UPLOAD
Letter from SEC
30 Nov 22
S-3
Shelf registration
22 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Apyx Medical Corporation Reports Third Quarter 2022 Financial Results
10 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
17 Aug 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
8-K
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
11 Aug 22
8-K
Other Events
18 Jul 22
DEF 14A
Definitive proxy
24 Jun 22
8-K
Other Events
13 Jun 22
SD
Conflict minerals disclosure
27 May 22
8-K
Other Events
26 May 22
Latest ownership filings
SC 13D
Archon Capital Management LLC
5 Apr 24
SC 13D
Vizirgianakis Stavros G.
1 Apr 24
SC 13G/A
HIRSCHMAN ORIN
25 Mar 24
SC 13G/A
PURA VIDA INVESTMENTS, LLC
14 Feb 24
SC 13G/A
Divisadero Street Capital Management, LP
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
Archon Capital Management LLC
13 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
SC 13G
ROYCE & ASSOCIATES LP
23 Jan 24
SC 13G/A
ROYCE & ASSOCIATES LP
23 Jan 24
4
MOSHE CITRONOWICZ
11 Jan 24
4
Todd Hornsby
11 Jan 24
4
MATTHEW C HILL
11 Jan 24
4
Charles D. Goodwin II
11 Jan 24
4
MATTHEW C HILL
14 Dec 23
3
MATTHEW C HILL
6 Dec 23
4
Charles D. Goodwin II
15 Nov 23
4
Craig A. Swandal
15 Aug 23
4
Minnie Baylor-Henry
15 Aug 23
4
Wendy Lauren Levine
15 Aug 23
4
Lawrence Waldman
15 Aug 23
4
Michael Geraghty
15 Aug 23
4
ANDREW MAKRIDES
15 Aug 23
4
John C. Andres
15 Aug 23
SC 13G
HIRSCHMAN ORIN
14 Aug 23
4
Lawrence Waldman
19 Jul 23
4/A
Todd Hornsby
29 Jun 23
4
Todd Hornsby
28 Jun 23
144
Notice of proposed sale of securities
21 Jun 23
SC 13G/A
HIRSCHMAN ORIN
13 Jun 23
4
Michael Geraghty
9 Jun 23
SC 13G
Divisadero Street Capital Management, LP
19 May 23
SC 13G
HIRSCHMAN ORIN
12 May 23
4
Craig A. Swandal
22 Mar 23
SC 13G/A
PURA VIDA INVESTMENTS, LLC
14 Feb 23
SC 13G/A
Archon Capital Management LLC
13 Feb 23
4
Todd Hornsby
13 Jan 23
4
MOSHE CITRONOWICZ
13 Jan 23
4
Tara Semb
13 Jan 23